Project Number 3U54GM115371-05S1 Agency/Funding Organization NIGMS Funding Year 2020 View Full Project Details for Development of Novel Therapeutics for the Treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 6. Emerging Biomarkers a. Genomic Researcher and Organization Principal Investigator QUINN, MARK T Principal Investigator First Name MARK T Principal Investigator Last Name QUINN Awardee Organization MONTANA STATE UNIVERSITY - BOZEMAN Awardee State Montana Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $337,458 Funding Organization Agency/Funding Organization NIGMS Funding Organization Country United States Program Official JUSTINOVA, ZUZANA
